Gyre Therapeutics, Inc. ( GYRE) - Stock Earnings
GYRE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
GYRE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.7 million USD | 37.2 million USD |
| 2026Q1 | -8.6 million USD | 22.5 million USD |
| 2026Q2 | -10.6 million USD | 29.1 million USD |
| 2026Q4 Est. | — | — |
GYRE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.9 million USD | 113.5 million USD |
| 2024 | 12.1 million USD | 105.8 million USD |
| 2025 | 5.0 million USD | 116.6 million USD |
| 2026 Est. | — | — |
GYRE
Price: $6.14
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 792.7 million